A Collection of Articles
Edit

Business

Study: Genentech's Cancer Fighter Avastin Helps Sickest Patients

A new study found cancer patients treated with a new drug survived two months longer than those treated only with chemotherapy. With FDA approval and more detailed research coming out, Avastin could become the next hot cancer-fighting medicine.

Uh oh–you've read all five of your free articles for this month.

Insider basic

$29.95/yr US PRICE

Subscribe
What's Included
  • 1 year (6 issues) of MIT Technology Review magazine in print OR digital format
  • Access to the entire online story archive: 1997-present
  • Special discounts to select partners
  • Discounts to our events

You've read of free articles this month.